Daptacel (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed

The Aventis Mission

Our Mission

Creating vaccines, giving strength to life

A major medical breakthrough

Creating vaccines … the medical breakthrough that has led to great accomplishments in the prevention of infectious diseases. After more than a century, vaccination remains one of the most promising sources of hope for meeting the major challenges of individual and community health care.

A company, a mission

Creating vaccines is one of the missions of Aventis, achieved through the group's vaccines business, Aventis Pasteur. The history of our company is marked by discoveries that have led to advances in preventive medicine that have saved millions of lives.

Commited to innovate

Our commitment to innovation has become one of the company's main assets today. Innovation has allowed us to forge vital partnerships with cutting-edge biotechnology firms and major universities. Thanks to innovation, we have been able to maintain our competitive edge in an increasingly competitive environment. Our performance and our know-how have made us a world leader in the vaccine industry. Our success serves to illustrate the growing importance of vaccines for advancing health.

Creating vaccines is a commitment and a responsibility that we are proud to embrace.


This site provided as a service by sanofi pasteur

Safety Information

DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) is a vaccine given to infants and children 6 weeks through 6 years (prior to 7th birthday) to prevent 3 serious diseases: diphtheria, tetanus (lockjaw), and pertussis (whooping cough). As with any vaccine, vaccination with DAPTACEL vaccine may not protect 100% of individuals. There are risks associated with all vaccines. The most common side effects with DAPTACEL vaccine are redness, swelling, and soreness or tenderness where the injection was given; fever, fussiness, and crying more than usual. Other side effects may occur. DAPTACEL vaccine should not be given to children who, after a previous dose of the vaccine, have had a serious allergic reaction (anaphylactic reaction) or encephalopathy not attributable to another cause.

For more information about DAPTACEL vaccine, refer to the Patient Information on DAPTACEL.com and talk to your child's health-care provider.